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Chronic infections affect a third of the world’s popu-
lation and can cause bone marrow suppression, a
severe condition that increases mortality from infec-
tion. To uncover the basis for infection-associated
bone marrow suppression, we conducted repeated
infection of WT mice with Mycobacterium avium.
After 4–6 months, mice became pancytopenic. Their
hematopoietic stem and progenitor cells (HSPCs)
were severely depleted and displayed interferon
gamma (IFN-g) signaling-dependent defects in self-
renewal. There was no evidence of increased HSPC
mobilization or apoptosis. However, consistent with
known effects of IFN-g, transcriptome analysis
pointed toward increased myeloid differentiation of
HSPCs and revealed the transcription factor Batf2
as a potential mediator of IFN-g-induced HSPC dif-
ferentiation. Gain- and loss-of-function studies un-
covered a role for Batf2 in myeloid differentiation in
both murine and human systems. We thus demon-
strate that chronic infection can deplete HSPCs and
identify BATF2 as a mediator of infection-induced
HSPC terminal differentiation.
INTRODUCTION
Chronic infections including tuberculosis (2 billion infected
worldwide; CDC), hepatitis C virus (180 million; WHO), and HIV
(34 million; NIH) are estimated to affect over a third of the world’s
population. These diseases are associated with significant
health implications including bone marrow suppression and an
increased risk for cancer (Ramos-Casals et al., 2003; Scadden
et al., 1989). Pancytopenia, a suppression of blood counts
across multiple lineages, can affect as many as 12% of people2584 Cell Reports 17, 2584–2595, December 6, 2016 ª 2016 The Au
This is an open access article under the CC BY-NC-ND license (http://with disseminated or miliary tuberculosis and increases risk of
death from the infection (Achi et al., 2013). Collectively, these ob-
servations suggest that chronic infections may significantly
affect the function of hematopoietic stem cells (HSCs), the pro-
genitor cells of all blood cells. Thus, understanding the long-
term effects of inflammation on HSC number and function is a
matter of key clinical importance.
Production of blood cells by the bone marrow is a highly dy-
namic process. An estimated 1011–1012 blood cells are pro-
duced by hematopoietic progenitors in the bone marrow on a
daily basis, and this number increases during infection (Takizawa
et al., 2012). Primitive hematopoietic stem and progenitor cells
(HSPCs) are the precursors of all cells of the peripheral blood
(PB) and are responsible for maintaining healthy blood produc-
tion. HSPCs include not only long-term HSCs, which have self-
renewal capacity, but also multipotent progenitors (MPPs),
which do not. Recent work suggests that HSPCs can generate
restricted subsets of terminally differentiated progeny, bypass-
ing the stepwise progression through common myeloid progen-
itor (CMP) and common lymphoid progenitor (CLP) stages (Notta
et al., 2016). Thus, directed differentiation of blood cells may be
driven by signals that act at the earliest stages of the hematopoi-
etic hierarchy.
In fact, HSCs are highly responsive to the inflammatory con-
ditions that exist during a typical infection (Takizawa et al.,
2012), and a variety of signals can affect HSC function during
infection. HSCs express pathogen pattern recognition recep-
tors such as Toll-like receptor 4. Bacterial products sensed
by these receptors alter HSC quiescence and function (Balmer
et al., 2014; Nagai et al., 2006). Inflammatory signals propa-
gated by the immune system can also affect HSC function,
and interferons (IFNs) are particularly powerful regulators of
HSCs (King and Goodell, 2011). For example, IFN-a signaling
can promote HSC division (Essers et al., 2009; Pietras et al.,
2014). We previously showed that IFN-g stimulates cell divi-
sion of HSCs in a murine model ofMycobacterium avium infec-
tion, leading to a defect in repopulation capacity (Baldridgethor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Chronically Infected Mice Develop Pancytopenia and Severe HSC Loss
(A–C) Mice were infected withM. avium every 4 weeks for 1–6 months. Bone marrow and PB were assessed 4 weeks after the final injection. (A) White blood cell
(WBC), (B) red blood cell (RBC), and (C) platelet counts decline with chronic infection.
(D) WBC counts do not recover following cessation of infections in 4-month-infected mice.
(E and F) The number of HSCs (KL CD150+ CD48– CD34–) after repeated M. avium infections. (E) Percentage of live WBM cells. (F) Absolute number per bone.
(G) Total engraftment of PB, shown as percentage CD45.2 cells of total blood, 16 weeks after transplant. 2 3 105 WBM cells from naive or infected animals
(CD45.2) were mixed with 2 3 105 rescue marrow (CD45.1) and transplanted into lethally irradiated mice.
(H) Progenitor populations in the bone marrow of naive and 6-month infected mice, shown as absolute number of cells per bone. Data are presented as mean ±
SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
Data are representative of two (A–C, F, and G), three (E), or four (D) independent experiments; n = 3–5 per group. See also Figure S1 and Table S1.et al., 2010). Furthermore, short-term IFN-g-mediated HSC di-
vision appears to accelerate differentiation during infection
(Matatall et al., 2014); however, both the long-term impact
and the mechanism of these processes remain unknown.
Here, we capitalize on our murine model ofM. avium infection
to evaluate the impact of chronic infection on the HSC pool.
M. avium typically produces a chronic (10 weeks) systemic
IFN-g-mediated immune response in mice similar to what can
be seen in patients with tuberculosis (Flo´rido et al., 2005). We
show that chronic infection drives exhaustion of the HSC
compartment, with depletion of both PB counts and HSC
self-renewal capacity. We use this model to evaluate the
mechanisms of HSC loss and identify a potential mediator of
stress-induced myeloid specification. Our study thus provides
direct evidence for how infections and persistent inflammation
affect the HSC population and elicit diseases associated with
HSC loss.RESULTS
Chronically Infected Mice Develop Pancytopenia
To characterize the effects of chronic infection on bone marrow
function, we conducted repeatedmonthly infections of micewith
M. avium. PB of infected animals showed a progressive decline
in all cell types, reaching statistical significance by 1–2months of
infection (Figures 1A–1C). Several mice appeared nearly mori-
bund after 6 months. After 4 months, the hematopoietic effects
of infection were irreversible (Figure 1D).
Chronic Infection Depletes HSCs
We characterized hematopoietic progenitors in the bonemarrow
of chronically infected animals. The number of phenotypically
defined long-term HSCs (lineage-negative, cKit-positive [LK]
CD150+ CD48– CD34–) declined during the course of infection;
by 4 months of infection only 5.7% of the starting number ofCell Reports 17, 2584–2595, December 6, 2016 2585
Figure 2. HSCs from Chronically Infected Animals Have a Self-Renewal Defect
(A and B) 300 sorted CD45.2 HSCs (SPLSK CD150+) from naive or M. avium-infected mice were transplanted with 2 3 105 CD45.1 rescue marrow into lethally
irradiated mice. Donor mice were infected with M. avium three, four, five, or six times (once every 4 weeks); the four- and five-dose mice were pooled before
transplant. PB was assessed at 16 weeks post-transplant. (A) Total engraftment is shown as percentage of CD45.2 cells in total blood. (B) Lineage distribution of
T cells, B cells, and myeloid cells is shown as percentage of total CD45.2 cells.
(C) Secondary transplant of 250 sorted CD45.2 HSCs (SP LSK CD150+) from previously transplanted animals. Donor HSCs were co-transplanted with 2 3 105
CD45.1 rescue marrow into lethally irradiated mice. PB was assessed 16 weeks post-transplant, and engraftment is shown as percentage of CD45.2 cells in
blood. Data are presented asmean ±SEM; *p < 0.05. Except for secondary transplant done oncewith n = 5 per group, data are representative of two independent
experiments with n = 5 per group.HSCs remained (Figures 1E, 1F, S1B, and S1C). This decline in
stem cell number outstripped the rate ofweight loss (Figure S1A),
suggesting that stem cell loss was not due to nutritional deficit.
The stem cell marker Sca1 was intentionally excluded because
it can be non-specifically activated during infection (Baldridge
et al., 2011). In addition, we found that the number of myeloid-
biased HSCs was more depressed than the lymphoid-biased
HSCs (Figure S1D) (Matatall et al., 2014). This decrease was
also manifest by a decline in the absolute number of myeloid
cells derived from transplanted marrow (Figure S1E). There
was a consistent rebound in the number of HSCs as a percent-
age of whole-bone marrow (WBM) at 2 months post-infection
across four repetitions of the chronic infection experiment (Fig-
ure 1E), suggesting that the bonemarrow can initially adapt to in-
flammatory responses but that such compensatory processes
are eventually overwhelmed.
To assess the number of functionally defined HSCs in chroni-
cally infected animals, we transplanted 2 3 105 WBM cells
from infected animals with 2 3 105 rescue marrow into lethally
irradiated naive recipient animals. As shown in Figure 1G,
WBM engraftment declined after chronic infection, mirroring
the decline in phenotypically defined HSCs. To determine
whether reduced engraftment was due to transmitted infection,
we cultured WBM cells in methylcellulose, which does not sup-
port the growth of mycobacteria. WBM of chronically infected
animals generated significantly fewer total cells after 9 days of in-
cubation compared to control WBM, suggesting that loss of
HSPCs was not due to direct infection of the cells (Figure S1F).
Collectively, these data indicate that HSCs are depleted during
chronic infection.
We quantified the presence of committed lymphoid and
myeloid progenitors in the marrow during chronic infection. After
6 months of infection, the number of CLPs was steady, but the
number of myeloid progenitors including CMPs, granulocyte-
monocyte progenitors (GMPs), and megakaryocyte-erythrocyte
progenitors (MEPs) was reduced (Figure 1G), indicating myeloid2586 Cell Reports 17, 2584–2595, December 6, 2016progenitors are more easily exhausted during chronic M. avium
infection than lymphoid progenitors.
HSCs from Chronically Infected Animals Show a Self-
Renewal Defect upon Secondary Transplant
To ascertain whether cell-autonomous defects occur in HSC
function upon chronic infection, we sorted LT-HSCs (SPLSK
CD150+) from naive or infected animals and transplanted 300
cells along with rescue marrow into lethally irradiated recipients.
As shown in Figure 2A, sorted LT-HSCs were equally capable of
reconstituting the marrow of recipient animals at 16 weeks post-
transplant, regardless of infection. Lineage distribution of cells
derived from transplanted cells was not affected by chronic
infection (Figure 2B). These findings indicate that while the total
number of LT-HSCs was decreased in chronically infected ani-
mals, their ability to reconstitute long-term hematopoiesis upon
primary transplantation was not impaired.
To evaluate the self-renewal capacity of HSCs from infected
animals, we conducted secondary transplant. Secondary
engraftment of sorted HSCs from chronically infected mice
was significantly diminished compared to HSCs from naive ani-
mals, and HSCs from animals that had been infected for the
longest time were most severely affected (Figure 2C). Thus, sec-
ondary transplants revealed a self-renewal defect in HSCs from
chronically infected mice, indicating that HSC exhaustion can
occur following persistent infectious stimulation.
Loss of HSCs Precedes Marrow Fibrosis
Most medical textbooks ascribe pancytopenia associated with
chronic infections such as tuberculosis to marrow fibrosis (Fitz-
gerald and Haas, 2005). However, a causal relationship between
myelofibrosis and bonemarrow suppression during infection has
not been firmly established (Viallard et al., 2002). Using trichrome
staining, we found that patches of marrow fibrosis became
evident after only 1 month of infection, but remained limited
to small areas of the marrow through 6 months of infection
Figure 3. Myeloid Cells Infiltrate Bone Marrow during Chronic Infection
(A) H&E-stained sections of bone marrow from naive and chronically infected animals.
(B and C) Flow cytometry of WBM cells from naive, 1-month-, or 4-month-infected animals. Absolute number of cells per bone is shown. Data in (B) and (C) are
presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Data are representative of two independent experiments with n = 4–7 per group. See also Figures S2 and S3.(Figure S2A). Overall, marrow of infected mice demonstrated
progressively reduced cellularity (Figure S2B), but neither the
loss in cellularity nor the degree of fibrosis was sufficient to ac-
count for the 95% loss in HSCs by 4 months of infection.
H&E staining showed a relative increase of granulocytes and
monocytes which was confirmed by flow cytometry (Figures
3A, 3B, S2C, and S3). Meanwhile, the absolute number of
lymphoid cells in the bone marrow declined, with reductions in
B and T cells (Figures 3C and S2D), and all classes of B cell pre-
cursors and immature T cells (Figures S2E and S2F). Altogether,
these findings suggest that the rate of HSC loss outpaces the
rate of marrow fibrosis and that inflammatory changes, including
a relative increase in neutrophils and monocytes, can be seen
during chronic infection.
Impaired HSC Engraftment during M. Avium Infection Is
IFN-g Dependent
IFN-g is a key immune mediator during mycobacterial infections
and we previously showed that IFN-g alone can induce HSC di-
vision and differentiation (Baldridge et al., 2010). Here, we showthat IFN-g levels remained high in the serum of infected animals
even after 6 months of infection (Figure 4A). We also demon-
strate that IFN-g is highly expressed by both T and natural killer
(NK) cells in the bone marrow of chronically infected animals
(Figure S4A).
To investigate the role of IFN-g in impaired HSC function dur-
ing infection, we infected wild-type (WT) or Ifngr1–/– mice with
M. avium and then transplanted their marrow into WT recipients.
We found that infection reduced the engraftment of HSCs from
WT animals. The trend was reversed in infected Ifngr1–/– mice,
with WBM from these mice engrafting at least as well as unin-
fected WT cells (Figure 4B). These findings suggest that IFN-g-
dependent effects impair the capacity of WT marrow to engraft
following infection. To confirm these findings, we created
mosaic animals by transplanting either WT or Ifngr1–/– marrow
into lethally irradiated WT recipients. Six weeks after transplant,
we infected test animals with M. avium, whereas control ani-
mals were uninfected. Engraftment was significantly curtailed
in recipients of infected WT marrow. In contrast, infection did
not affect engraftment in Ifngr1–/– marrow recipients (Figure 4C).Cell Reports 17, 2584–2595, December 6, 2016 2587
Figure 4. Impaired HSC Engraftment after M. avium Infection Is IFN-g Dependent and Does Not Involve HSC Mobilization
(A) Mice were infected withM. avium every 4 weeks for 1–6 months. IFN-g levels in serum of chronically infected mice determined by ELISA. One experiment with
n = 2–5 per group.
(B) Engraftment of 23 105 WBM cells fromWT or Ifngr1/ mice that were naive or infected for 1 month withM. avium. One experiment with n = 9–10 per group.
(C) Engraftment of WT or Ifngr1/ mosaic transplants at 2 weeks pre- and 12 weeks post-infection. Mice were transplanted with either 2 3 105 WT or 3 3 105
Ifngr1/ bonemarrow with 23 105 rescuemarrow. Transplant recipients were infected withM. avium 6 weeks post-transplant. Data represent four independent
experiments with n = 7–14 per group.
(D) The number of HSCs in the spleen was assessed in mice that had been treated with G-CSF and/or IFN-g and is shown as percentage of Lin-
cKit+CD150+CD48– cells of total leukocytes.
Data represent two independent experiments with n = 2–3 per group. Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, n.s., not significant.
See also Figure S4.Collectively, these findings suggest that functional deficits in
HSCs during M. avium infection are attributable to IFN-g expo-
sure via a cell-autonomous mechanism.
Mathematical Modeling of HSC Loss during Chronic
Infection
The decline in total HSC number during chronic infection implies
an increase in the rate of HSC loss. To estimate the magnitude
of HSC loss during infection, we created a mathematical model
of hematopoiesis using differential equations based on steady
state parameters: total number of HSCs, division rate, rate of
self-renewal versus loss, and time (cf. Estimation of HSC Loss
in the Experimental Procedures). We assumed that HSCs can
be lost through death, differentiation, or displacement. Thus,
we used an aggregate variable d to reflect the overall proportion
of HSCs lost per division event, where d = 0.5 indicates complete
self-renewal and d = 1 indicates complete loss (no progeny are
HSCs). We applied our data from chronic infection to this model
and concluded that the d must increase from d = 0.5 at the
steady state to a median value of 0.788 during chronic infection
to account for the dramatic loss of HSCs observed (Figure S1G).
In other words, whereas at steady state each HSC division
produces one new HSC and one cell that is ‘‘lost’’ through differ-2588 Cell Reports 17, 2584–2595, December 6, 2016entiation, displacement, or death, during infection the percent-
age of HSC loss goes up by 57%. As might be expected,
we observed a very large inter-individual heterogeneity of the
response, as reflected in the wide 95% confidence interval
(0.729–0.954) for d (Figure S1H; Table S1).
Infection Does Not Induce HSC Mobilization
We sought to understand the mechanism by which HSCs
were lost during chronic infection. We previously reported that
lineage-negative, Sca1-positive, cKit-positive (LSK) CD150+
CD48– cells are increased in the spleens of M. avium-infected
animals, suggesting that displacement from the bone marrow
niche is a potential mechanism for HSC loss (Baldridge et al.,
2010). However, a more recent report indicated that HSCs are
not mobilized from bone marrow during chronic E. chafeensis
infection (McCabe et al., 2015). We therefore performed mobili-
zation studies using IFN-g and granulocyte colony-stimulating
factor (G-CSF). While G-CSF increased the number of HSCs
(LK CD150+ CD48– CD34– Flk2–) in the spleen as expected,
IFN-g treatment did not. Co-administration of IFN-g with
G-CSF did not further boost the number of HSCs detectible in
the spleen (Figure 4D). These results were confirmed upon trans-
plantation of splenocytes from animals after G-CSF or IFN-g
treatment (Figure S4B), suggesting that IFN-g does not induce
HSC mobilization from the bone marrow.
HSCs from Chronically Infected Animals Are Not
Actively Apoptotic
We next considered cell death as a potential mechanism of HSC
loss during chronic infection. We previously reported that HSCs
are induced to divide during infection (Baldridge et al., 2010), and
a recent report linked increased cell division with accumulation
of DNA damage and attrition of HSCs by apoptosis (Walter
et al., 2015). Furthermore, cell death can be triggered in HSCs
upon secondary stress after IFN-a stimulation (Pietras et al.,
2014). Therefore, we investigated whether persistent infection
could impose increased replication stress on HSCs, leading to
increased apoptosis. We confirmed that cell-cycle activity,
determined by Ki67 staining, was high in HSCs even after
months of infection (Figure 5A). Next, we measured reactive ox-
ygen species (ROS) in the HSCs of infected animals. Compared
to HSCs from naive animals, we saw no increase in ROS in LK
CD150+ CD48– HSCs (Figure 5B). However, we did note a slight
increase in DNA damage in HSCs from chronically infected mice
as measured by pKap1 staining and gH2AX staining (Figures 5C
and 5D), but these increases wereminor compared to the degree
of DNA damage measured in the positive controls.
To test for activation of apoptosis upon secondary stress, we
incubated HSCs for 12 hr ex vivo and then measured caspase
activation. Following this secondary stress, apoptosis was
increased in HSCs from mice that had been infected for 1 or
3months compared to controls (Figure 5E). To ascertain whether
stress-induced apoptosis is related to IFN-g stimulation, we
treated mice with recombinant IFN-g for 24 hr and then incu-
bated HSCs from these mice for 12 hr ex vivo. The IFN-g-treated
cells showed elevated caspase activation compared to HSCs
from control mice (Figure 5F). We also compared the effect of
M. avium infection on stress-induced apoptosis in WT versus
Ifngr1/ mice. In contrast to WT, HSCs from infected Ifngr1/
mice did not show stress-induced apoptosis, again highlighting
that this effect is IFN-g dependent (Figure S5A).
As a secondary measure of cell survival, we sorted HSCs
singly into 96-well plates containing complete stem cell media.
The number of colonies formed under these stressful ex vivo
conditions was diminished for cells derived from mice that had
been infected for 1 or 4 months or from animals treated with
IFN-g, consistent with a lower threshold for apoptosis in
these cells (Figure S5B). These findings indicate that chronic
M. avium infection or transient IFN-g exposure can make HSCs
more susceptible to apoptosis upon secondary stress.
As HSCs from infected or IFN-g-treated animals had an
increased propensity for apoptosis following ex vivo secondary
stress, we investigated whether the rate of apoptosis was
increased during infection in vivo.We isolated HSCs from control
or infected mice and immediately measured caspase activation
(Figures 5G and S5C). Caspase activation was not noted in
HSCs from naive or infected mice immediately after cell sorting
and was far from the level that would have been required by
mathematical models to account for the loss in HSC number.
Thus, even though IFN-g stimulation can lower the threshold
for apoptosis in HSCs, an increased rate of apoptosis wasnot detectible among HSCs during in vivo infection. Therefore,
we conclude that apoptosis alone cannot account for signifi-
cant loss of HSCs observed during chronic infection in vivo
(Figure S1G).
Transcriptional Profiling of HSCs from Chronically
Infected Animals Reveals Increased Differentiation
To further characterize potential mechanisms of HSC loss during
chronic infection, we sorted HSCs from naive mice and mice in-
fected for 1 month with M. avium and conducted whole-tran-
scriptome analysis by RNA sequencing (Figure 6A; Table S2).
HSCs from infected animals demonstrated increased expression
of Stat1, Cxcl9, and the interferon responsive GTPase Irgm1,
consistent with an ongoing TH1-type inflammatory response
(Figure 6B) (King et al., 2011). Gene ontology analysis of the
RNA sequencing (RNA-seq) data revealed a strong upregulation
of genes associated with antigen processing and presentation
and immune responses including major histocompatibility com-
plex II genes, suggesting a shift toward gene expression signa-
tures of myeloid cells such as macrophages and dendritic cells
(Figure 6C). Genes related to apoptosis and cell death were strik-
ingly absent, further supporting the lack of apoptosis noted in the
studies described above. Upon gene set enrichment analysis
(GSEA), the only major category significantly enriched was
antigen processing and presentation (Figure 6D), pointing to-
ward myeloid differentiation as the major transcriptional change
occurring in HSCs during infection.
To understand the extent to which IFN-g promotes myeloid
differentiation of HSPCs, we isolated CD34+ cells from human
Buffy coat samples and treated them with IFN-g in vitro. Within
3 days, the number of CD34+CD38– stem cells decreased by
7-fold compared to untreated control cells. Meanwhile, there
was a dramatic increase in cells with the phenotype of differen-
tiated myeloid cells, particularly CD15+ myelomonocytic cells
and CD66b+ granulocytes, consistent with a prior report (Figures
S6A and S6B) (Yang et al., 2005). These data show that IFN-g
can induce amajor shift toward differentiation in HSCs on a scale
that would be sufficient to deplete the HSC population.
Overexpression of Batf2 Drives Myeloid Differentiation
of HSPCs
We hypothesized that terminal differentiation may be the major
mechanism of HSC loss during chronic infection. To identify mo-
lecular drivers of this process, we focused on the four transcrip-
tion factors upregulated during infection. Aside from expected
increases in expression of Stat1, NFkappaB, and Ciita, Batf2,
an IFN-g-responsive transcription factor, was significantly upre-
gulated in HSCs duringM. avium infection (Table S2; Figure 6B).
This transcription factor caught our attention because it has
been previously reported to participate in dendritic cell develop-
ment during stress (Tussiwand et al., 2012). The Batf2 family
member Batf acts as a differentiation checkpoint that limits
HSC self-renewal in response to DNA damage while promoting
lymphoid differentiation (Santos et al., 2014; Wang et al.,
2012). We assayed transcript levels from HSCs by qPCR
and found that Batf2 was upregulated 8-fold in HSCs during
M. avium infection (Figure 7A). Furthermore, we found that
Batf2 was not induced when M. avium infection was conductedCell Reports 17, 2584–2595, December 6, 2016 2589
Figure 5. HSCs from Chronically Infected Animals Have Increased Stress but No Increase in Rate of Apoptosis
(A) Ki67+ HSCs shown as percentage of total HSCs (LK CD150+ CD48– CD34–) in naive, 1-month, or 3-month M. avium-infected mice. Data represent two
independent experiments, with n = 6–10 per group.
(B) ROS levels in HSCs of naive and 4-week M. avium-infected mice shown as a mean fluorescent intensity (MFI) of CellRox staining. Tert-Butyl hydroperoxide
(TBHP) was the positive control. Data represent two independent experiments, n = 6–8 per group.
(C) DNA damage was assessed using phospho-Kap1 (pKap1) staining of HSCs from naive or M. avium-infected mice. UV-treated cells were used as positive
control. Data are representative of two independent studies, n = 3–5 per group.
(D) Percentage of HSCs with gH2AX staining. Numbers above the bars refer to n for each condition. 1-Gy irradiation was used as a positive control. Data are
representative of two independent experiments.
(E and F) Caspase 3/7 activity in 400 HSCs after 12 hr of in vitro culture. (E) HSCs from 1- or 3-month-infected mice. (F) HSCs from control or 24-hr IFN-g-treated
mice.
(G) Caspase 3/7 activity immediately after isolation of 400 HSCs from naive or M. avium-infected mice.
Results for (E)–(G) are representative of two to five independent experiments, n = 3 per group. Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p <
0.001, n.s., not significant. See also Figure S5.in Ifngr1/ mice, suggesting that IFN-g signaling is required for
its upregulation. In order to test the relevance of this gene in the
human system, we measured BATF2 expression in primary hu-2590 Cell Reports 17, 2584–2595, December 6, 2016man CD34+ cells. We found that BATF2 expression was detecti-
ble in human CD34+ progenitors and was significantly increased
upon addition of IFN-g to the culture media (Figure 7B).
Figure 6. Transcriptional Profiling of HSCs from Chronically Infected Animals Reveals Increased Differentiation
(A) Heatmap of differentially expressed genes (FDR <0.1) from RNA-seq data of naive compared to M. avium-infected HSCs.
(B) Fold change in the normalized read counts of Stat1, Irgm1, Cxcl9, and Batf2 between M. avium-infected and naive HSCs.
(C) Gene ontology (GO) analysis of RNA-seq data from HSCs isolated from naive and 4-weekM. avium-infected mice. Analyses were performed for differentially
expressed genes with an FDR <0.1. Log10 FDR adjusted p values are shown on the x axis.
(D) Gene set enrichment analysis (GSEA) was performed on RNA-seq data from naive and 4-week M. avium-infected mice. Antigen processing and presentation
pathways are highly enriched (p < 0.001, normalized enrichment score [NES] = 2.05) in the M. avium-induced upregulated genes.To test the role of Batf2 in hematopoietic progenitors, we
overexpressed Batf2 using a retroviral vector in Sca1+ murine
progenitors. Overexpression was verified by qPCR (Figure S7A).
Hematopoietic progenitors overexpressing Batf2 demonstrated
a trend toward increased early myeloid differentiation 8 weeks
after transplantation into lethally irradiated WT recipients
(Figure 7C). Since Batf familymembers are known to act in coop-
eration with cofactors such as Irf1 (Roy et al., 2015), the observa-
tion that myeloid differentiation was even modestly increased
without additional expression of cofactors was striking. In
contrast to control cells overexpressing GFP alone, the overall
engraftment of Batf2-overexpressing clones declined between
4 and 8weeks post-transplant, showing that engraftment capac-
ity is impaired (Figures 7D and 7E). These findings suggest that
Batf2-dependent myeloid differentiation may be a mechanism
for HSPC loss during chronic infection.
BATF2 Loss of Function Impairs Myeloid Differentiation
of Human HSPCs
To test whether Batf2 is required for myeloid differentiation
of HSPCs, we used CRISPR-Cas9 gene editing to knock out
BATF2 in human CD34+ cord-blood-derived progenitors (Gun-dry et al., 2016; Ran et al., 2013). Four separate single-guide
RNAs were designed to target the first exon of BATF2; spacing
between PAM sequences of these guides was out of frame
with one another. Genotyping by PCR revealed that the effi-
ciency of deletion was high, with 50% of template DNA
showing a large 139-bp deletion, representing just one of the
16 potential combinations by which the four guides could disrupt
the gene (Figures 7F and S7B). Gene expression was no longer
detectible by real-time qPCR in the gene-edited cells, indicating
a high efficiency of deletion (Figure 7G).We next conducted a dif-
ferentiation assay of CD34+ progenitors in vitro. Briefly, gene edi-
ted CD34+ cells were incubated in complete media in the pres-
ence or absence of IFN-g for 3 days, and the number of HSCs
(CD34+CD38–), progenitors (CD34+CD38+), and differentiated
myeloid cells (CD15+ or CD66b+) were counted. The final cell
counts per well were not statistically different between IFN-g-
treated and untreated groups. While HSCs were diminished in
both Cas9-only control and KO cells (Figure S7C), BATF2 KO
CD34+ cells differentiated less efficiently into myeloid progeny.
Specifically, the IFN-g-mediated induction of CD66b+ granulo-
cytes was completely abrogated in KO cells (Figure 7H), while
the percentage of CD15+ myelomonocytic cells decreased andCell Reports 17, 2584–2595, December 6, 2016 2591
Figure 7. Batf2 Promotes IFN-g-Dependent Myeloid Differentiation in Murine and Human Cells
(A) Batf2RNA expression in HSCs (KL CD150+ CD48– CD34–) of WT or Ifngr1/mice 4 weeks afterM. avium infection shown as fold change over WT naive. Data
are representative of two independent experiments both performed in triplicate.
(B) BATF2 expression measured from umbilical cord-blood-derived human CD34+ cells in the presence or absence of rhIFN-g for 3 days. Data are representative
of two independent experiments using different cord blood samples, performed in triplicate.
(C–E) Sca1-enriched cells were transduced with retroviruses overexpressing GFP alone or GFP-Batf2. 2,000 CD45.2 Sca1+ transduced cells were transplanted
with 2 3 105 CD45.1 rescue WBM cells. Data represent five independent experiments with n = 13–14 per group. (C) Lineage distribution of murine PB 8 weeks
after transplant. (D) Engraftment of GFP+ CD45.2 cells at 4 and 8weeks post-transplant. (E) Change in engraftment of GFP+ CD45.2+ cells between 4 and 8weeks
post-transplant.
(F–H) Human cord-blood-derived CD34+ cells after gene editing with Cas9-only control or Cas9 plus four BATF2 single guide RNAs (sgRNAs).
(F) Representative DNA gel of BATF2 exon 1 region.
(G) BATF2 RNA expression. Data are representative of two independent experiments performed in triplicate.
(H) Percentage of cells that express the granulocyte marker CD66b+ in the absence or presence of rhIFN-g 3 3 days. Data are representative of three
independent experiments each in triplicate. Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S7 and
Table S3.their absolute number trended down (Figures S7C and S7D).
Meanwhile the number of CD34+CD38+ progenitors in BATF2
KO samples increased, consistent with a differentiation block
(Figures S7C and S7D). These studies identify BATF2 as a medi-
ator of IFN-g-dependent terminal differentiation of human he-
matopoietic progenitors.2592 Cell Reports 17, 2584–2595, December 6, 2016DISCUSSION
Here, we demonstrated that chronic infection with M. avium
leads to pancytopenia, depletion of bone marrow HSCs, and
impaired HSC self-renewal. While HSCs from infected animals
are exposed to increased replication stress and are more prone
to apoptosis upon secondary stress, we found no evidence of
increased HSC apoptosis during in vivo infection. Furthermore,
there was no evidence of HSC mobilization out of the bone
marrow during infection. Instead, RNA profiling data pointed
toward differentiation as the most significant transcriptional
change. We identified Batf2 as a potential mediator of HSPC dif-
ferentiation and used gain- and loss-of-function studies to show
that Batf2 impairs HSPC persistence and is required for normal
IFN-g-dependent myeloid differentiation in human progenitors.
These studies suggest that increased terminal differentiation
is the major route of HSC loss during chronic infection and pro-
vide a direct mechanism by which chronic infection causes HSC
depletion.
Bone marrow suppression and pancytopenia are known com-
plications of chronic infectious diseases including mycobacterial
infections (Achi et al., 2013). Since mycobacterial infections
frequently co-occur with myelofibrosis, many have assumed
that pancytopenia is due to physical disruption of the bone
marrow (Viallard et al., 2002). However, our data indicate that
inflammatory stimulation of HSCs is a more significant contrib-
utor to pancytopenia than myelofibrosis. In another study,
recruitment of bone marrow macrophages by IFN-g was also
found to contribute to HSC dysfunction and loss (McCabe
et al., 2015).
Our findings are consistent with several studies using murine
knockout models to demonstrate that dysregulated IFN-
signaling depletes hematopoietic progenitors, including stem
cells (Essers et al., 2009; King et al., 2011; Lin et al., 2014;
Sato et al., 2009). These studies using genetically modified
mice suggest that artificially elevated IFN- signaling can damage
self-renewal processes and deplete hematopoietic progenitor
populations over time. Our study demonstrates that this occurs
in the context of physiologic infection in WT mice.
Although IFN-g did not promote HSC mobilization, our results
do not rule out the possibility that HSCs are displaced from
cellular niches with the bone marrow architecture as has been
shown for IFN-a (Kunisaki et al., 2013), nor do they rule out the
possibility that HSCs in extramedullary sites could expand
through self-renewal events. Prior studies have demonstrated
increased apoptosis of HSPCs in aplastic anemia patients with
high IFN-g levels through both in vitro and in vivo assays in hu-
man cells (Zeng et al., 2006). Our studies suggest that inflamma-
tion and IFN-g stimulation may affect HSPCs on a continuum;
while we did not detect increased apoptosis during infection,
we did find that the threshold for apoptosis was lowered. People
with aplastic anemia may have multiple stressors, for example
microenvironmental changes in the bone marrow niche in addi-
tion to increased IFN-g levels, that together lead to apoptosis.
We identified Batf2 as a potential mediator of IFN-g-depen-
dent terminal HSPC differentiation. Our demonstration that
BATF2 has a key role in IFN-g-dependent myeloid differentiation
may contribute to the development of future applications to pro-
tect stem cells in the context of persistent inflammation. How-
ever, Batf2 is likely not the only mediator of IFN-g-dependent
myeloid differentiation, and our RNA-seq data may reveal other
key regulators. In addition, although we focused on IFN-g as a
powerful mediator of HSC loss during infection, it is almost
certainly not the only one. HSCs lacking IFN-g receptors canalso respond to this signal indirectly via the release of inter-
leukin-6 (IL-6) from the microenvironment (Sch€urch et al.,
2014). Chronic LPS exposure was shown to injure HSC function
(Esplin et al., 2011). A recent study reported that IL-1 proinflam-
matory signaling accelerates myeloid differentiation of HSPCs
through activation of the transcription factor Pu.1 (Pietras
et al., 2016). Other infections with less IFN-g-dominant inflam-
matory signatures may cause distinct hematological effects.
Our demonstration that HSCs are significantly depleted
during chronic infection may have significant implications in
the field of hematologic malignancies. Infections are epidemio-
logically linked to acute myelogenous leukemia (Kristinsson
et al., 2011), and dysregulation of inflammation is an important
contributor to aplastic anemia, which can evolve to cancer
(Gan˜a´n-Go´mez et al., 2015; Young and Maciejewski, 1997).
Given recent reports of clonal hematopoiesis as a risk factor
for malignancy (Yoshizato et al., 2015), attrition in HSC numbers
due to persistent inflammation could provide a pathophysiologic
basis for these links. Further work to delineate the effects of
inflammation on HSCs is likely to yield important mechanistic
insight into other diseases of HSC malfunction, including tran-
sient bonemarrow suppression, aplastic anemia, myelodysplas-
tic syndrome, and leukemia.
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6 (CD45.2) and C57BL/6.SJL (CD45.1) mice 6–12 weeks
of age were used. C57BL/6 Ifngr1/ (Stock #3288) mice were obtained
from Jackson Laboratory. All mice were maintained at an AALAC-accredited,
specific pathogen-free animal facility at Baylor College of Medicine. All exper-
iments were approved by the institutional review board of Baylor College of
Medicine. Genotypes were confirmed by PCR.
Microbial Infections
Mice were infected monthly with 2 3 106 colony-forming units of Mycobacte-
rium avium i.v. as described (Feng et al., 2008). M. avium was detected by
growth on Middlebrook agar and by PCR (Park et al., 2000).
Bone Marrow Transplantation
Non-competitive bone marrow transplants were performed by intravenous
(i.v.) injection of CD45.2 donor WBM cells from infected mice or naive controls
into lethally irradiated CD45.1 WT recipients. For competitive transplants,
CD45.2 donor WBM cells from naive or infected mice were mixed with wild-
type CD45.1 competitor WBM cells prior to injection into CD45.1 recipients.
For secondary transplants, sorted CD45.2 donor HSCs were isolated from pri-
mary recipients and transplanted with CD45.1 rescue WBM into naive CD45.1
irradiated recipients.
RNA Purification and RNA-Seq
Approximately 70,000 HSCs (SPLSKCD150+) were sorted into Trizol from the
pools of naive or infected mice. RNA was isolated with the RNeasy Micro col-
umn (QIAGEN). Illumina HiSeq was used for sequencing with a paired-end
sequencing length of 100 bp. False discovery rate (FDR) <0.05was considered
statistically significant. Gene ontology and pathway analyses were performed
for differentially expressed genes with FDR <0.1.
Flow Cytometry
PBwas analyzedwith a Hemavet 950. SP staining was performedwith Hoechst
33342 (Sigma) as previously described (Goodell et al., 1996). Myeloid-biased
and lymphoid-biased HSCs were identified as previously described (Challen
et al., 2010). A full list of all staining schemesandantibodies is provided in Tables
S4 and S5.Cell Reports 17, 2584–2595, December 6, 2016 2593
Colony-Forming Assays
Colony-forming assays were performed by plating WBM cells in methylcellu-
lose media and counting colonies after 9 days (STEMCELL Technologies).
Single-Cell Assays
Single HSCs (KSL CD150+ CD48– CD34–) were sorted into 96-well plates con-
taining StemSpan media, and colonies were counted after 10 days.
Cell Proliferation and DNA Damage
Proliferation and DNA damage of HSCs was determined using flow cytometry
of cells co-stained with Ki67 and pKap1. gH2AX staining was performed on
sorted HSCs from naive or 4-month M. avium-infected mice as previously
described (Walter et al., 2015).
Reactive Oxygen Species
Levels of ROS within HSCs from control or infected mice were determined by
flow cytometry analysis of cells stained with Molecular Probes’ CellRox Green
Flow Cytometry Assay Kit (Life Technologies) according to the manufacturer’s
protocol.
Apoptosis Assays
Apoptosis was determined using the Caspase-Glo 3/7 Assay (Promega).
HSCs were sorted directly into 96-well plates containing StemSpan media
and Caspase Glo reagent was either immediately added to the wells or was
added after 12 hr incubation at 37C.
Batf2 Overexpression and BATF2 Deletion
Batf2 was overexpressed in Sca1+ cells using a retrovirus as previously
described (Ergen et al., 2012). Sca1+ CD45.2 cells were transplanted into
lethally irradiated CD45.1 recipient mice along with rescue marrow, and
engraftment of theGFP+CD45.2 cells was tracked every 4weeks. BATF2 dele-
tion was conducted as described (Gundry et al., 2016). For each experiment,
CD34+ cellswere isolated froman unrelated frozen humanumbilical cord blood
or Buffy coat sample. Four single-guide RNAs (Table S3) were mixed with re-
combinant Cas9 protein and transduced into CD34+ cells by electroporation.
Gene deletion was confirmed by PCR and qPCR. Differentiation of human cells
was measured by incubation of CD34+ cells with IFN-g for 3 days. HSPCs and
differentiated myeloid cells were characterized by flow cytometry.
Mobilization Assays
Mice were treated with G-CSF for 6 days and/or rmIFN-g for 24 hr prior to sac-
rifice. HSCs were detected in the spleen by flow cytometry. For transplants,
splenocytes were mixed with CD45.1 rescue WBM cells and transplanted
into lethally irradiated CD45.1 recipients.
Estimation of HSC Loss
The basis for understanding the dynamics of HSC loss is the differential equa-
tion of the form _NðtÞ=  lNðtÞ+ 2ð1 dÞlNðtÞ where NðtÞ is the HSC count at
time t, l is the division rate of theHSC, and d is the fraction of HSCprogeny that
are not HSC (i.e., that constitutes HSC ‘‘loss’’). The equation admits explicit
solution NðtÞ=Nð0Þexp½ð1 2dÞlt, where the initial condition Nð0Þ is equal
to the pre-infection steady-state HSC count. Logarithm of the HSC count is
a linear function of ln½Nð0Þ and d, and therefore these two quantities can be
estimated using standard linear regression, if the value of l is assumed (we
set l = 0.05 d–1) (Wilson et al., 2008). Given that (1) each measurement corre-
sponds to a different mouse (represented by the asterisks in Figure S1G), and
(2) HSC counts show wide interindividual variability, we estimated the vari-
ability in any time point with at least two replicates by fitting a gamma distribu-
tion. Then we fit regression lines to the quantiles of orders 2.5%, 5%, 25%,
50%, 75%, 95%, and 97.5% of the gamma distributions. These lines (Fig-
ure S1G) provide corresponding quantile values of Nð0Þ and d (Table S1),
yielding the 95% confidence interval for d.
Statistics
Mean values ± SEM are shown. Student’s t test or two-way ANOVAwere used
for comparisons (GraphPad Prism v.5.0).
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